High Risk Atherosclerosis Identified at Cardiac CT Among Patients With vs Without Family History of CAD
1 other identifier
observational
480
1 country
1
Brief Summary
Acute coronary syndrome often represtent the first drammatic manifestation of coronary atherosclerosis. Cardiac computed tomography angiography (CCTA) has recently gained a pivotal role in the evalution of patients with suspected coronary artery disease (CAD). Of inteterst, it may provide important information on coronary atherosclerosis beyond lumen stenosis; more precisely high risk plaque features could be identified even in the abesence of significative lumen stenosis (i.e. not flow-limiting lesions). The evidence of non-obstructive but high risk atheroscleorisis may support aggressive primary prevention treatment, reducing the risk of future cardiovascular events. Even if familty history of CAD is considered a risk factor for cardiovascular events, no clear data are available regarding the prevalence of coronary atherosclerosis in this subgroup of patients and CCTA in asymptomatic subjects is not clearly supported by evidence nor suggested by guidelines. Aim of our study is to explore whether the prevalence of high risk coronary atherosclerosis among patients with family hystory of CAD is different when compared with a group of patients without family hystory of CAD. For that purpose from consecutive registry of patient who underwent clinically indicated CCTA for suspected but unknown CAD a cohort of patients with family history of CAD as first early presentation of coronary atherosclerosis (group 1) will be compared with a consecutive cohort of subjects without familiy history of CAD (group 2). All CCTA will be perfomed according to most recent guidelines and advanced atheroscleoris analysis will be performed. As primary objective of the study, the prevalence of high risk atherosclerosis will be compared between the two Groups. The evidence of higher prevalence of high-risk atherosclerosis prevalence in group 1 vs group 2 may further support the use of CCTA in asymptomatic patients but with family history of CAD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 31, 2025
CompletedFirst Posted
Study publicly available on registry
September 15, 2025
CompletedSeptember 15, 2025
September 1, 2025
4 months
August 31, 2025
September 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Identification of high risk atherosclerosis at coronary computed tomography angiography (CCTA)
the present is a trasveral descriptive study. No follow-up will be performed and all parameters will be evaluated at the time of CCTA acquisition (Day 1)
Day 1
Eligibility Criteria
History of any adverse reaction to contrast medium * History of any severe allergic reactions * Previous history of chronic kidney disease (eGFR\<30 ml/min/1.73m2) * Previous history of cardiovascular disease, including documented asymptomatic atherosclerosis
You may qualify if:
- Group 1
- Patients with clinical indation to CCTA for suspected CAD with family history of CAD
- Age \>40 years old for male and \>50 years old for female
- No history of previous cardiovascular disease Group 2
- Patients with clinical indation to CCTA for suspected CAD without family history of CAD
- Age \>40 years old for male and \>50 years old for female
- No history of previous cardiovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head Scientific Direction
Study Record Dates
First Submitted
August 31, 2025
First Posted
September 15, 2025
Study Start
January 15, 2025
Primary Completion
May 15, 2025
Study Completion
August 1, 2025
Last Updated
September 15, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share